Weight Loss Drugs As US Prescriptions Skyrocket
Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 2023. Prescriptions of appetite suppressing GLP-1 weight-loss drugs skyrocketed 300% from 2020 to 2022. Photographer: George Frey/Bloomberg via Getty Images
PURCHASE A LICENCE
How can I use this image?
335.00 €
EUR
Getty ImagesWeight Loss Drugs As US Prescriptions Skyrocket, News Photo
Weight Loss Drugs As US Prescriptions Skyrocket Get premium, high resolution news photos at Getty ImagesProduct #:1807240018
Weight Loss Drugs As US Prescriptions Skyrocket Get premium, high resolution news photos at Getty ImagesProduct #:1807240018475€150€
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Editorial #:
1807240018
Collection:
Bloomberg
Date created:
27 November, 2023
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
WEIGHT LOSS DRUGS
Max file size:
5298 x 3532 px (44.86 x 29.90 cm) - 300 dpi - 6 MB